435 related articles for article (PubMed ID: 18219297)
1. beta1- and beta2-adrenergic receptor gene variation, beta-blocker use and risk of myocardial infarction and stroke.
Lemaitre RN; Heckbert SR; Sotoodehnia N; Bis JC; Smith NL; Marciante KD; Hindorff LA; Lange LA; Lumley TS; Rice KM; Wiggins KL; Psaty BM
Am J Hypertens; 2008 Mar; 21(3):290-6. PubMed ID: 18219297
[TBL] [Abstract][Full Text] [Related]
2. Beta2-adrenergic receptor gene polymorphisms and risk of ischemic stroke.
Stanzione R; Di Angelantonio E; Evangelista A; Barbato D; Marchitti S; Zanda B; Pirisi A; Quarta G; Volpe M; Rubattu S
Am J Hypertens; 2007 Jun; 20(6):657-62. PubMed ID: 17531924
[TBL] [Abstract][Full Text] [Related]
3. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
4. Angiotensinogen M235T polymorphism and the risk of myocardial infarction and stroke among hypertensive patients on ACE-inhibitors or beta-blockers.
Schelleman H; Klungel OH; Witteman JC; Breteler MM; Yazdanpanah M; Danser AH; Hofman A; van Duijn CM; de Boer A; Stricker BH
Eur J Hum Genet; 2007 Apr; 15(4):478-84. PubMed ID: 17299437
[TBL] [Abstract][Full Text] [Related]
5. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin system haplotypes and the risk of myocardial infarction and stroke in pharmacologically treated hypertensive patients.
Marciante KD; Bis JC; Rieder MJ; Reiner AP; Lumley T; Monks SA; Kooperberg C; Carlson C; Heckbert SR; Psaty BM
Am J Epidemiol; 2007 Jul; 166(1):19-27. PubMed ID: 17522061
[TBL] [Abstract][Full Text] [Related]
7. Interaction between polymorphisms in the renin-angiotensin-system and angiotensin-converting enzyme inhibitor or beta-blocker use and the risk of myocardial infarction and stroke.
Schelleman H; Klungel OH; Witteman JC; Breteler MM; Hofman A; van Duijn CM; de Boer A; Stricker BH
Pharmacogenomics J; 2008 Dec; 8(6):400-7. PubMed ID: 18347611
[TBL] [Abstract][Full Text] [Related]
8. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
9. The myocardial infarction associated CDKN2A/CDKN2B locus on chromosome 9p21 is associated with stroke independently of coronary events in patients with hypertension.
Wahlstrand B; Orho-Melander M; Delling L; Kjeldsen S; Narkiewicz K; Almgren P; Hedner T; Melander O
J Hypertens; 2009 Apr; 27(4):769-73. PubMed ID: 19293724
[TBL] [Abstract][Full Text] [Related]
10. Knowledge of cardiovascular risk factors and awareness of non-pharmacological approach for risk prevention in young survivors of acute myocardial infarction. The cardiovascular risk prevention project "Help Your Heart Stay Young".
Migliaresi P; Celentano A; Palmieri V; Pezzullo S; Martino S; Bonito M; Guillaro B; Brancati C; Di Minno G
Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):468-72. PubMed ID: 17379491
[TBL] [Abstract][Full Text] [Related]
11. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy.
Badenhorst D; Norton GR; Sliwa K; Brooksbank R; Essop R; Sareli P; Woodiwiss AJ
Pharmacogenomics J; 2007 Oct; 7(5):339-45. PubMed ID: 17117186
[TBL] [Abstract][Full Text] [Related]
12. Common variation in cytochrome P450 epoxygenase genes and the risk of incident nonfatal myocardial infarction and ischemic stroke.
Marciante KD; Totah RA; Heckbert SR; Smith NL; Lemaitre RN; Lumley T; Rice KM; Hindorff LA; Bis JC; Hartman B; Psaty BM
Pharmacogenet Genomics; 2008 Jun; 18(6):535-43. PubMed ID: 18496133
[TBL] [Abstract][Full Text] [Related]
13. The E27 beta2-adrenergic receptor polymorphism reduces the risk of myocardial infarction in dyslipidemic young males.
Sala G; Di Castelnuovo A; Cuomo L; Gattone M; Giannuzzi P; Iacoviello L; De Blasi A
Thromb Haemost; 2001 Feb; 85(2):231-3. PubMed ID: 11246538
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
Volpe M; Tocci G; Sciarretta S; Verdecchia P; Trimarco B; Mancia G
J Hypertens; 2009 May; 27(5):941-6. PubMed ID: 19381108
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensives and myocardial infarction risk: the modifying effect of history of drug use.
Bourgault C; Elstein E; Baltzan MA; Le Lorier J; Suissa S
Pharmacoepidemiol Drug Saf; 2001; 10(4):287-94. PubMed ID: 11760488
[TBL] [Abstract][Full Text] [Related]
16. Variants in the coagulation factor 2 receptor (F2R) gene influence the risk of myocardial infarction in men through an interaction with interleukin 6 serum levels.
Gigante B; Vikström M; Meuzelaar LS; Chernogubova E; Silveira A; Hooft FV; Hamsten A; de Faire U
Thromb Haemost; 2009 May; 101(5):943-53. PubMed ID: 19404549
[TBL] [Abstract][Full Text] [Related]
17. The potential preventability of postoperative myocardial infarction: underuse of perioperative beta-adrenergic blockade.
Lindenauer PK; Fitzgerald J; Hoople N; Benjamin EM
Arch Intern Med; 2004 Apr; 164(7):762-6. PubMed ID: 15078646
[TBL] [Abstract][Full Text] [Related]
18. Specific beta1-adrenergic receptor silencing with small interfering RNA lowers high blood pressure and improves cardiac function in myocardial ischemia.
Arnold AS; Tang YL; Qian K; Shen L; Valencia V; Phillips MI; Zhang YC
J Hypertens; 2007 Jan; 25(1):197-205. PubMed ID: 17143192
[TBL] [Abstract][Full Text] [Related]
19. Use and adherence to beta-blockers for secondary prevention of myocardial infarction: who is not getting the treatment?
Wei L; Flynn R; Murray GD; MacDonald TM
Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):761-6. PubMed ID: 15386713
[TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking, carrier state of A or G allele of 46A>G and 79C>G polymorphisms of beta2-adrenergic receptor gene, and the risk of coronary artery disease.
Zak I; Sarecka-Hujar B; Krauze J
Kardiol Pol; 2008 Apr; 66(4):380-6; discussion 387. PubMed ID: 18473266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
